The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mass cytometry immune profiling to detect signatures of clinical activity of bintrafusp alfa (BA) in patients with advanced non-small cell lung cancer (NSCLC).
 
Meredith McAdams
No Relationships to Disclose
 
Carlos Medina
Employment - Teiko.bio
Stock and Other Ownership Interests - AstraZeneca; Becton Dickinson; Teiko.bio; Walgreens Boots Alliance
 
Connor Healy
Employment - Teiko.bio
Stock and Other Ownership Interests - Teiko.bio
Travel, Accommodations, Expenses - Teiko.bio
 
Renee N. Donahue
No Relationships to Disclose
 
Natalia Sigal
Employment - Teiko.bio
Stock and Other Ownership Interests - Teiko.bio
 
Elizabeth M. Enrico
Employment - Teiko.bio
 
Jenn Marte
No Relationships to Disclose
 
Jolien Sweere
Employment - Teiko.bio
 
Ramji Srinivasan
Employment - Teiko.bio
Leadership - Teiko.bio
Stock and Other Ownership Interests - Specie Bio; Teiko.bio
Consulting or Advisory Role - Curve Therapeutics; Specie Bio
 
Ngan Nguyen
Employment - Teiko.bio
Stock and Other Ownership Interests - Atreca
Research Funding - Teiko.bio
Patents, Royalties, Other Intellectual Property - Atreca
Travel, Accommodations, Expenses - Teiko.bio
 
Jeffrey Schlom
Research Funding - Bavarian Nordic (Inst); EMD Serono/Merck (Inst); ImmunityBio (Inst); Incyte (Inst); NextCure (Inst); PDS Biotechnology (Inst); Pfizer (Inst); Precigen (Inst); Syndax (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - If applicable; If applicable (Inst)
 
Arun Rajan
Research Funding - Bayer (Inst); EMD Serono/Merck (Inst); Promontory Therapeutics (Inst)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Marengo Therapeutics (Inst); Merck (Inst); NextCure (Inst); PDS Biotechnology (Inst); Pfizer (Inst); Precigen (Inst); Syndax (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Publication number: 20200062849 Abstract: The invention provides a method of inhibiting a malignancy associated with human papilloma virus (HPV) comprising administering to a subje